EUVIMEDEUVIMED entdecken
Open Access

Metabolic polygenic risk scores for prediction of obesity, type 2 diabetes, and related morbidities

Min Seo Kim, Qiuli Chen, Yang Sui, Xiong Yang, Shaoqi Wang, Lu-Chen Weng, So Mi Jemma Cho, Satoshi Koyama, Xinyu Zhu, Kang Yu, Xingyu Chen, Rufan Zhang und 8 weitere

Cell Metabolism · 2026-05 · 38 (5) · 863-875.e5

DOI: 10.1016/j.cmet.2026.02.009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Metabolism, 2026-05. Verfasst von Min Seo Kim und 19 weiteren Autor:innen. Beteiligte Einrichtung: Medical and Population Genetics and Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA, USA; Cardiovascular Researc…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Obesity, Multifactorial Inheritance. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: American Heart Association-American Stroke Association, NHLBI NIH HHS, NHGRI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity and type 2 diabetes (T2D) are metabolic diseases with shared pathophysiology. Traditional polygenic risk scores (PRSs) have focused on these conditions individually, yet the single-disease approach falls short in capturing the full dimension of metabolic dysfunction. We derived a biologically enriched metabolic PRS (MetPRS), a composite score that uses multi-ancestry genome-wide association studies of 20 metabolic traits from over 8.5 million individuals. MetPRS, optimized to predict obesity (O-MetPRS) and T2D (D-MetPRS), outperformed existing PRSs in predicting obesity and T2D across six ancestries. O-MetPRS and D-MetPRS effectively identify individuals at high risk for metabolic multimorbidity and predict clinical outcomes, including GLP-1 receptor agonist initiation. O-MetPRS and D-MetPRS showed an ∼2-fold increased risk of GLP-1 receptor agonist initiation for the top decile versus the middle quintile. The biologically enriched MetPRS has the potential to add an extra layer of information to disease prediction and management approaches for metabolic diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2ObesityMultifactorial InheritanceHumansGenetic Risk ScoreGenome-Wide Association StudyGenetic Predisposition to DiseaseRisk Factors

Stichwörter der Autor:innen

GLP-1 receptor agonistmetabolic traitsmulti-ancestry GWASmultimorbidityobesitypolygenic risk scoretype 2 diabetes

Autor:innen und Institutionen

  • Medical and Population Genetics and Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA, USA; Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA, USA; Heart and V…
  • National Genomics Data Center, China National Center for Bioinformation, Beijing 100101, China; Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100101, China; University of Chinese Academy of Science…
  • National Genomics Data Center, China National Center for Bioinformation, Beijing 100101, China; Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100101, China.
  • Medical and Population Genetics and Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA, USA; Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA, USA.
  • National Genomics Data Center, China National Center for Bioinformation, Beijing 100101, China; Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100101, China; College of Future Technology, Sino-Danis…
  • Department of Translational Genomics, Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia; Lifera Omics, Riyadh, Saudi Arabia; College of Medicine, Alfaisal University,…

Förderung

  • American Heart Association-American Stroke Association
  • NHLBI NIH HHS
  • NHGRI NIH HHS
  • NIH
  • Chinese Academy of Sciences

Zitieren

APA

Kim, M. S., Chen, Q., Sui, Y., Yang, X., Wang, S., Weng, L. C., Cho, S. M. J., Koyama, S., Zhu, X., Yu, K., Chen, X., Zhang, R., Yin, W., Liao, S., Liu, Z., Alkuraya, F. S., Natarajan, P., Ellinor, P. T., Fahed, A. C., & Wang, M. (2026). Metabolic polygenic risk scores for prediction of obesity, type 2 diabetes, and related morbidities. Cell Metabolism, 38(5), 863-875.e5. https://doi.org/10.1016/j.cmet.2026.02.009

Vancouver

Kim MS, Chen Q, Sui Y, Yang X, Wang S, Weng LC, et al. Metabolic polygenic risk scores for prediction of obesity, type 2 diabetes, and related morbidities. Cell Metabolism. 2026;38(5):863-875.e5. doi:10.1016/j.cmet.2026.02.009

BibTeX
@article{Kim2026,
  author = {Kim, Min Seo and Chen, Qiuli and Sui, Yang and Yang, Xiong and Wang, Shaoqi and Weng, Lu-Chen and Cho, So Mi Jemma and Koyama, Satoshi and Zhu, Xinyu and Yu, Kang and Chen, Xingyu and Zhang, Rufan and Yin, Wanqing and Liao, Shuangqiao and Liu, Zhaoqi and Alkuraya, Fowzan S and Natarajan, Pradeep and Ellinor, Patrick T and Fahed, Akl C and Wang, Minxian},
  title = {Metabolic polygenic risk scores for prediction of obesity, type 2 diabetes, and related morbidities},
  journal = {Cell Metabolism},
  year = {2026},
  volume = {38},
  number = {5},
  pages = {863--875.e5},
  doi = {10.1016/j.cmet.2026.02.009}
}
Kostenlos starten →